High materiality8/10
BNP Paribas Exane Upgrades Nutrien (NTR) to Outperform
Why it may matterVerify against the original reporting
Upgrade to Outperform signals bullish setup
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
BNP Paribas upgrades NTR to Outperform; target $80 vs price $67.40.
- Target $80; price $67.40
- Upside potential ~19%
Key facts
- 01
Target: $80
- 02
Posted price: $67.4
- 03
Analyst firm: BNP Paribas
- 04
Analyst: David Symonds
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.